BHF-177
![]() | |
Systematic (IUPAC) name | |
---|---|
N-[(1R,2R,4S)-bicyclo[2.2.1]hept-2-yl]-2-methyl-5-[4-(trifluoromethyl)phenyl]-4-pyrimidinamine | |
Identifiers | |
CAS Number |
917896-43-6 ![]() |
IUPHAR/BPS | 5503 |
ChemSpider |
26286940 ![]() |
Chemical data | |
Formula | C19H20F3N3 |
Molar mass | 347.377 g/mol |
| |
| |
(verify) |
BHF-177 is a compound used in scientific research which acts as a positive allosteric modulator at the GABAB receptor.[1] It was shown to reduce self-administration of nicotine in animal studies.[2]
References
- ↑ Guery, S; Floersheim, P; Kaupmann, K; Froestl, W (2007). "Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABAB receptors". Bioorganic & Medicinal Chemistry Letters 17 (22): 6206–11. doi:10.1016/j.bmcl.2007.09.023. PMC 2278029. PMID 17884493.
- ↑ Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, Markou A (2008). "Positive Modulation of GABAB Receptors Decreased Nicotine Self-administration and Counteracted Nicotine-induced Enhancement of Brain Reward Function in Rats". J. Pharmacol. Exp. Ther. 326 (1): 306–14. doi:10.1124/jpet.108.139204. PMC 2574924. PMID 18445779.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.